Structural highlights
Function
[PAR14_HUMAN] Enhances STAT6-dependent transcription (By similarity). Has ADP-ribosyltransferase activity.
Publication Abstract from PubMed
A series of (Z)-4-(3-carbamoylphenylamino)-4-oxobut-2-enyl amides were synthesized and tested for their ability to inhibit the mono-(ADP-ribosyl)transferase, PARP14 (a.k.a. BAL-2; ARTD-8). Two synthetic routes were established for this series and several compounds were identified as sub-micromolar inhibitors of PARP14, the most potent of which was compound 4t, IC50=160nM. Furthermore, profiling other members of this series identified compounds with >20-fold selectivity over PARP5a/TNKS1, and modest selectivity over PARP10, a closely related mono-(ADP-ribosyl)transferase.
Design and synthesis of potent inhibitors of the mono(ADP-ribosyl)transferase, PARP14.,Upton K, Meyers M, Thorsell AG, Karlberg T, Holechek J, Lease R, Schey G, Wolf E, Lucente A, Schuler H, Ferraris D Bioorg Med Chem Lett. 2017 Apr 29. pii: S0960-894X(17)30473-0. doi:, 10.1016/j.bmcl.2017.04.089. PMID:28495083[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Upton K, Meyers M, Thorsell AG, Karlberg T, Holechek J, Lease R, Schey G, Wolf E, Lucente A, Schuler H, Ferraris D. Design and synthesis of potent inhibitors of the mono(ADP-ribosyl)transferase, PARP14. Bioorg Med Chem Lett. 2017 Apr 29. pii: S0960-894X(17)30473-0. doi:, 10.1016/j.bmcl.2017.04.089. PMID:28495083 doi:http://dx.doi.org/10.1016/j.bmcl.2017.04.089
